Recovery of OATP1B Activity after Living Kidney Transplantation in Patients with End-Stage Renal Disease.
Yosuke SuzukiHiroyuki OnoRyota TanakaFuminori SatoYuhki SatoKeiko OhnoHiromitsu MimataHiroki ItohPublished in: Pharmaceutical research (2019)
OATP1B activity may decrease in renal failure and dose adjustment of OATP1B substrates may be needed in patients with renal failure.